Frontiers in Genetics (Feb 2021)

Case Report: Whole Exome Sequencing Revealed Disease-Causing Variants in Two Genes in a Patient With Autism Spectrum Disorder, Intellectual Disability, Hyperactivity, Sleep and Gastrointestinal Disturbances

  • Maria Cerminara,
  • Giovanni Spirito,
  • Livia Pisciotta,
  • Livia Pisciotta,
  • Margherita Squillario,
  • Martina Servetti,
  • Martina Servetti,
  • Maria Teresa Divizia,
  • Margherita Lerone,
  • Bianca Berloco,
  • Silvia Boeri,
  • Lino Nobili,
  • Lino Nobili,
  • Diego Vozzi,
  • Remo Sanges,
  • Remo Sanges,
  • Stefano Gustincich,
  • Aldamaria Puliti,
  • Aldamaria Puliti

DOI
https://doi.org/10.3389/fgene.2021.625564
Journal volume & issue
Vol. 12

Abstract

Read online

Autism Spectrum Disorder (ASD) refers to a broad range of conditions characterized by difficulties in communication, social interaction and behavior, and may be accompanied by other medical or psychiatric conditions. Patients with ASD and comorbidities are often difficult to diagnose because of the tendency to consider the multiple symptoms as the presentation of a complicated syndromic form. This view influences variant filtering which might ignore causative variants for specific clinical features shown by the patient. Here we report on a male child diagnosed with ASD, showing cognitive and motor impairments, stereotypies, hyperactivity, sleep, and gastrointestinal disturbances. The analysis of whole exome sequencing (WES) data with bioinformatic tools for oligogenic diseases helped us to identify two major previously unreported pathogenetic variants: a maternally inherited missense variant (p.R4122H) in HUWE1, an ubiquitin protein ligase associated to X-linked intellectual disability and ASD; and a de novo stop variant (p.Q259X) in TPH2, encoding the tryptophan hydroxylase 2 enzyme involved in serotonin synthesis and associated with susceptibility to attention deficit-hyperactivity disorder (ADHD). TPH2, expressed in central and peripheral nervous tissues, modulates various physiological functions, including gut motility and sleep. To the best of our knowledge, this is the first case presenting with ASD, cognitive impairment, sleep, and gastrointestinal disturbances linked to both HUWE1 and TPH2 genes. Our findings could contribute to the existing knowledge on clinical and genetic diagnosis of patients with ASD presentation with comorbidities.

Keywords